License and Collaborative Agreements (Details) (USD $)	3 Months Ended				12 Months Ended	3 Months Ended		1 Months Ended		3 Months Ended
	Mar. 31, 2013 Licensing Agreements [Member] University of Southern California [Member]	Mar. 31, 2012 Licensing Agreements [Member] University of Southern California [Member]	Mar. 31, 2013 Licensing Agreements [Member] Roche Molecular Systems [Member]	Mar. 31, 2012 Licensing Agreements [Member] Roche Molecular Systems [Member]	Dec. 31, 2012 Licensing Agreements [Member] Glaxo, Smith, Kline [Member]	Mar. 31, 2013 Service Agreements [Member] Taiho Pharmaceutical Co., Ltd. [Member]	Mar. 31, 2012 Service Agreements [Member] Taiho Pharmaceutical Co., Ltd. [Member]	Jan. 31, 2010 Service Agreements [Member] GlaxoSmithKline, LLC [Member]	Jan. 31, 2006 Service Agreements [Member] GlaxoSmithKline, LLC [Member]	Mar. 31, 2013 Service Agreements [Member] GlaxoSmithKline, LLC [Member]	Mar. 31, 2012 Service Agreements [Member] GlaxoSmithKline, LLC [Member]	Mar. 31, 2013 Service Agreements [Member] GSK Bio [Member]	Mar. 31, 2012 Service Agreements [Member] GSK Bio [Member]	Mar. 31, 2013 Collaborative Arrangement [Member] Hitachi Chemical Co., Ltd. [Member]	Mar. 31, 2012 Collaborative Arrangement [Member] Hitachi Chemical Co., Ltd. [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty expense included in cost of revenue	$ 104,105	$ 56,502	$ 90,145	$ 63,468
Revenue recognized						33,920	244,125			0	77,477	1,356,384	641,610	0	85,920
Revenue deferred								1,300,000	2,000,000
Milestone payment received					$ 500,000
Collaborative agreement, optional additional period										1 year
Collaborative agreement, term										2 years
Collaborative agreement, automatic renewal period														1 year
Collaborative agreement, termination notice period												90 days